Abstract:Lung cancer is the leading cause of cancer-related mortality worldwide. Despite progress in the treatment of non-small-cell lung cancer, there are limited treatment options for lung squamous cell carcinoma (LUSC), compared with lung adenocarcinoma. The present study investigated the disease mechanism of LUSC in order to identify key candidate genes for diagnosis and therapy. A total of three gene expression profiles (GSE19188, GSE21933 and GSE74706) were analyzed using GEO2R to identify common differentially expressed genes (DEGs). The DEGs were then investigated using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis. A protein-protein interaction (PPI) network was constructed via the Search Tool for the Retrieval of Interacting Genes/Proteins, and visualized using Cytoscape software. The expression levels of the hub genes identified using CytoHubba were validated using the University of California, Santa Cruz (UCSC) database and the Human Protein Atlas. A Kaplan-Meier curve and Gene Expression Profiling Interactive Analysis were then employed to evaluate the associated prognosis and clinical pathological stage of the hub genes. Furthermore, non-coding RNA regulatory networks were constructed using the Gene-Cloud Biotechnology information website. A total of 359 common DEGs (155 upregulated and 204 downregulated) were identified, which were predominantly enriched in ‘mitotic nuclear division’, ‘cell division’, ‘cell cycle’ and ‘p53 signaling pathway’. The PPI network consisted of 257 nodes and 2,772 edges, and the most significant module consisted of 66 upregulated genes. A total of 19 hub genes exhibited elevated RNA levels, and 10 hub genes had elevated protein levels compared with normal lung tissues. The upregulation of five hub genes (CCNB1, CEP55, FOXM1, MKI67 and TYMS; defined in Table I) were significantly associated with poor overall survival and unfavorable clinical pathological stages. Various ncRNAs, such as C1orf220, LINC01561 and MGC39584, may also play important roles in hub-gene regulation. In conclusion, the present study provides further understanding of the pathogenesis of LUSC, and reveals CCNB1, CEP55, FOXM1, MKI67 and TYMS as potential biomarkers or therapeutic targets.

The Diagnostic and Therapeutic Potential of the Epigenetic Modifications of Lung Cancer–Related Genes

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Identification Of Genetic Mutations In Human Lung Cancer By Targeted Sequencing

Regulatory Roles of Epigenetic Modulators, Modifiers and Mediators in Lung Cancer

[A Review of Epigenetic Modifications Regulate MicroRNA Expression in Lung Cancer]

Identification of Genes Associated with Lung Adenocarcinoma Prognosis

Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer

A review of current developments in RNA modifications in lung cancer

Novel Methylation-Driven Genes Identified As Prognostic Indicators for Lung Squamous Cell Carcinoma

RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer

Exploration of Lung Cancer-Related Genetic Factors via Mendelian Randomization Method Based on Genomic and Transcriptomic Summarized Data

Role of Epigenetics in Lung Cancer Heterogeneity and Clinical Implication.

Epigenetic changes driven by environmental pollutants in lung carcinogenesis: a comprehensive review

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis

Comprehensive Epigenetic Analyses Reveal Master Regulators Driving Lung Metastasis of Breast Cancer

An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance

Lung Cancer and Its Association with Chronic Obstructive Pulmonary Disease: Update on Nexus of Epigenetics

Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer

A Genome-Wide Comprehensive Analysis of Alterations in Driver Genes in Non-Small-cell Lung Cancer

DNA Methylation and Non-small Cell Lung Cancer

Gene Set Enrichment Analysis and Meta-Analysis Identified 12 Key Genes Regulating and Controlling the Prognosis of Lung Adenocarcinoma